Stay updated with breaking news from Polypid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PolyPid (NASDAQ:PYPD – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, August 9th. Parties that wish to listen to the company’s conference call can do so using this link. PolyPid (NASDAQ:PYPD – Get Free Report) last posted its quarterly earnings results on Wednesday, May 10th. The […]
PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover […]
PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the target of a large drop in short interest in June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover ratio is currently […]
05.06.2023 - PETACH TIKVA, Israel, June 05, 2023 (GLOBE NEWSWIRE) - PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced it has received an extension of the period to ... Seite 1
PolyPid Ltd. (NASDAQ:PYPD – Get Rating) shares traded up 4.8% during trading on Wednesday . The stock traded as high as $0.39 and last traded at $0.37. 94,833 shares were traded during trading, a decline of 67% from the average session volume of 288,958 shares. The stock had previously closed at $0.35. PolyPid Price Performance […]